IP Library › Granted Patent US 12,629,114
Granted Patent B2
US 12,629,114 · App. 19/390,467 · Granted May 19, 2026

Radiation shield assembly

Inventors: Robert Evans Foster (Birmingham, AL); Lloyd Guyton Bowers Cooper (Birmingham, AL); William Thomas Livingston (Birmingham, AL); Foster D. Phillips (Birmingham, AL)
Assignee: RAMPART IC, Inc.
A61B6/107G21F3/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,629,114
App. No.
19/390,467
Granted
May 19, 2026
Kind
B2
Abstract

A radiation shield assembly is described, configured to block radiation emanating from a radiation source from reaching a user. Two shields are supported by a support arm, and are configured to rotate and translate relative to one another about the support arm's longitudinal axis. This allows the shield to be easily configured and reconfigured as necessary to visualize various parts of a patient's body via radiography.

Claims (56)

1 . A radiation shield assembly, comprising:

a first radiation shield panel;

a second radiation shield panel,

wherein the first radiation shield panel and the second radiation shield panel are (i) composed of a rigid material, and (ii) at least partially transparent to visible light;

a vertical member positioned between and coupled to the first radiation shield panel and the second radiation shield panel, wherein the second radiation shield panel is configured to rotate relative to the first radiation shield panel about an axis defined by the vertical member; and

a support structure including a support arm coupled to an uppermost portion of the first radiation shield panel, wherein the support arm is configured to move the first radiation shield panel and the second radiation shield panel between a first operative configuration in which the first radiation shield panel and the second radiation shield panel are positioned in a transverse position over and/or across an operating bed, and a second operative configuration in which the first radiation shield panel and the second radiation shield panel are positioned parallel to a side of the operating bed.

2 . The radiation shield assembly of claim 1 wherein the support arm extends upward from the uppermost portion of the first radiation shield panel.

3 . The radiation shield assembly of claim 1 wherein the support arm is substantially parallel to the vertical member.

4 . The radiation shield assembly of claim 1 wherein the support arm is a first support arm, and wherein the support structure includes a second support arm coupled to the first support arm via an articulatable joint.

5 . The radiation shield assembly of claim 1 wherein the support structure is configured to suspend the first radiation shield panel and the second radiation shield panel entirely above a height of an operating table.

6 . The radiation shield assembly of claim 1 wherein the support structure is configured to be mounted to a wall.

7 . The radiation shield assembly of claim 1 wherein the support structure is configured to be mounted to a floor via a mobile stand.

8 . The radiation shield assembly of claim 1 wherein each of the first radiation shield panel and the second radiation shield panel is planar.

9 . The radiation shield assembly of claim 1 wherein the vertical member extends along an entire length of the first radiation shield panel and the second radiation shield panel.

10 . The radiation shield assembly of claim 1 wherein a lower edge of the first radiation shield panel is positionable at a different height than a lower edge of the second radiation shield panel.

11 . The radiation shield assembly of claim 1 wherein the second radiation shield panel has a substantially straight bottom edge.

12 . The radiation shield assembly of claim 1 wherein the vertical member includes a cylindrical rod.

13 . A radiation shield assembly, comprising:

a first radiation shield panel;

a second radiation shield panel,

wherein the first radiation shield panel and the second radiation shield panel are (i) composed of a rigid material, and (ii) at least partially transparent to visible light;

a vertical member positioned between and coupled to the first radiation shield panel and the second radiation shield panel, wherein the second radiation shield panel is configured to rotate relative to the first radiation shield panel about an axis defined by the vertical member; and

a support structure including a support arm coupled to an uppermost portion of the first radiation shield panel, wherein the support arm is moveable to control a position of both the first radiation shield panel and the second radiation shield panel.

14 . The radiation shield assembly of claim 13 wherein the support arm extends upward from the uppermost portion of the first radiation shield panel.

15 . The radiation shield assembly of claim 13 wherein the support arm is substantially parallel to the vertical member.

16 . The radiation shield assembly of claim 13 wherein each of the first radiation shield panel and the second radiation shield panel are planar.

17 . The radiation shield assembly of claim 13 wherein the vertical member extends along an entire length of the first radiation shield panel and the second radiation shield panel.

18 . The radiation shield assembly of claim 13 wherein a lower edge of the first radiation shield panel is positionable at a different height than a lower edge of the second radiation shield panel.

19 . The radiation shield assembly of claim 13 wherein the second radiation shield panel has a substantially straight bottom edge.

20 . The radiation shield assembly of claim 13 , further comprising a flexible radiopaque shroud coupled to a bottom edge of the first radiation shield panel.

21 . The radiation shield assembly of claim 13 wherein each of the first radiation shield panel and the second radiation shield panel has a radiopacity of about 1.0 mm lead equivalent.

22 . A radiation shield assembly, comprising:

a first radiation shield panel;

a second radiation shield panel,

wherein—

the first radiation shield panel and the second radiation shield panel are composed of a rigid material,

the first radiation shield panel and the second radiation shield panel are planar, and

the first radiation shield panel and the second radiation shield panel are at least partially transparent to visible light;

a vertical member positioned between and coupled to the first radiation shield panel and the second radiation shield panel; and

a support structure including a support arm coupled to an uppermost portion of the first radiation shield panel, wherein the support arm is moveable to control a position of both the first radiation shield panel and the second radiation shield panel.

23 . The radiation shield assembly of claim 22 wherein an entirety of the first radiation shield panel and the second radiation shield panel is rigid.

24 . The radiation shield assembly of claim 22 wherein the vertical member includes a hinge.

25 . The radiation shield assembly of claim 24 wherein the second radiation shield panel is configured to rotate relative to the first radiation shield panel about the hinge.

26 . The radiation shield assembly of claim 22 wherein the support structure is configured to suspend the first radiation shield panel and the second radiation shield panel entirely above a height of an operating table.

27 . The radiation shield assembly of claim 22 wherein the vertical member extends along an entire length of the first radiation shield panel and the second radiation shield panel.

28 . The radiation shield assembly of claim 22 wherein a lower edge of the first radiation shield panel is positionable at a different height than a lower edge of the second radiation shield panel.

29 . The radiation shield assembly of claim 22 wherein the second radiation shield panel has a substantially straight bottom edge.

30 . A radiation shield assembly, comprising:

a first radiation shield panel;

a second radiation shield panel,

wherein the first radiation shield panel and the second radiation shield panel are (i) composed of a rigid material, (ii) planar, and (iii) at least partially transparent to visible light, and

wherein the second radiation shield panel has a substantially straight bottom edge;

a vertical member positioned between and coupled to the first radiation shield panel and the second radiation shield panel, wherein the vertical member extends along an entire length of the first radiation shield panel and the second radiation shield panel, and wherein the second radiation shield panel is configured to rotate relative to the first radiation shield panel about an axis defined by the vertical member; and

a support structure including a support arm coupled to an uppermost portion of the first radiation shield panel, wherein the support arm is configured to:

suspend the first radiation shield panel and the second radiation shield panel entirely above a height of an operating table, and

move the first radiation shield panel and the second radiation shield panel between a first operative configuration in which the first radiation shield panel and the second radiation shield panel are positioned in a transverse position over and/or across an operating bed, and a second operative configuration in which the first radiation shield panel and the second radiation shield panel are positioned parallel to a side of the operating bed.

Continuity (5)
Continuation 18909841 · Oct 8, 2024
Continuation 17525011 · Nov 12, 2021
Continuation 16083393
Provisional Application 62544468 · Aug 11, 2017
Related Publication 20260069225A1 · Mar 12, 2026
References Cited (233)
US 3308297A · Mansker · 1967 [cited by applicant]
US 3984696A · Collica et al. · 1976 [cited by applicant]
US 4254341A · Herr et al. · 1981 [cited by applicant]
US 4280056A · Renshaw · 1981 [cited by applicant]
US 4581538A · Lenhart · 1986 [cited by applicant]
US D300945S · Fleming et al. · 1989 [cited by applicant]
US 4923162A · Fleming et al. · 1990 [cited by applicant]
US 4965456A · Huettenrauch et al. · 1990 [cited by applicant]
US 5006718A · Lenhart · 1991 [cited by applicant]
US 5015864A · Maleki · 1991 [cited by applicant]
US 5090044A · Kobayashi · 1992 [cited by applicant]
US 5417225A · Rubenstein et al. · 1995 [cited by applicant]
US 5981964A · McAuley et al. · 1999 [cited by applicant]
US 6325538B1 · Heesch · 2001 [cited by applicant]
US 6448571B1 · Goldstein · 2002 [cited by applicant]
US 6703632B1 · Macklis et al. · 2004 [cited by applicant]
US 7276716B1 · Munro, III · 2007 [cited by applicant]
US 7331712B2 · Fischer et al. · 2008 [cited by applicant]
US 7391042B2 · Goldstein · 2008 [cited by applicant]
US 7465947B2 · Magram · 2008 [cited by applicant]
US 7608847B2 · Rees · 2009 [cited by applicant]
US 7638784B2 · Fox et al. · 2009 [cited by applicant]
US 7829873B2 · Fox et al. · 2010 [cited by applicant]
US 7973299B2 · Rees · 2011 [cited by applicant]
US 8143607B2 · Teodorescu · 2012 [cited by applicant]
US 8378326B2 · Hunt · 2013 [cited by applicant]
US 8399871B2 · Beyar et al. · 2013 [cited by applicant]
US 8439564B2 · Belson et al. · 2013 [cited by applicant]
US 8558204B2 · Rees · 2013 [cited by applicant]
US 8598554B2 · Rees · 2013 [cited by applicant]
US 8683928B2 · Anderson · 2014 [cited by applicant]
US 8716687B2 · Goldstein et al. · 2014 [cited by applicant]
US 9349492B1 · Ganus · 2016 [cited by applicant]
US D772414S · Ballsieper · 2016 [cited by applicant]
US 9867583B1 · Colling · 2018 [cited by applicant]
US 9877688B1 · Colling · 2018 [cited by applicant]
US 10016172B2 · Wilson et al. · 2018 [cited by applicant]
US 10062463B2 · Inanami et al. · 2018 [cited by applicant]
US 10441231B2 · Wilson et al. · 2019 [cited by applicant]
US 11045155B2 · Lemer · 2021 [cited by applicant]
US 11191495B2 · Wilson et al. · 2021 [cited by applicant]
US 11204222B1 · Boucher · 2021 [cited by applicant]
US 11207039B2 · Foster et al. · 2021 [cited by applicant]
US 11219566B2 · Wilson et al. · 2022 [cited by applicant]
US 11660056B2 · Foster et al. · 2023 [cited by applicant]
US 11666290B2 · Wilson et al. · 2023 [cited by applicant]
US 11931304B2 · Wilson et al. · 2024 [cited by applicant]
US 12053312B2 · Wilson et al. · 2024 [cited by applicant]
US 12156754B2 · Foster et al. · 2024 [cited by applicant]
US 20040045557A1 · Lee · 2004 [cited by examiner]
US 20060076522A1 · Goldstein · 2006 [cited by applicant]
US 20060251219A1 · Cadwalader et al. · 2006 [cited by applicant]
US 20070252095A1 · Magram · 2007 [cited by examiner]
US 20100000002A1 · Rees · 2010 [cited by examiner]
US 20100319713A1 · Byers et al. · 2010 [cited by applicant]
US 20110174997A1 · Rees · 2011 [cited by applicant]
US 20120049093A1 · Costea · 2012 [cited by applicant]
US 20120132217A1 · Rees · 2012 [cited by applicant]
US 20120241652A1 · Jeschke · 2012 [cited by applicant]
US 20120256092A1 · Zingerman · 2012 [cited by applicant]
US 20130320246A1 · Beck · 2013 [cited by applicant]
US 20140048730A1 · Niedzielski et al. · 2014 [cited by applicant]
US 20150272519A1 · Buchmeyer · 2015 [cited by applicant]
US 20150335297A1 · Mogul et al. · 2015 [cited by applicant]
US 20160015336A1 · Ballsieper · 2016 [cited by applicant]
US 20160027540A1 · Gordon et al. · 2016 [cited by applicant]
US 20160029980A1 · Osherov et al. · 2016 [cited by applicant]
US 20160038365A1 · Conner et al. · 2016 [cited by applicant]
US 20160158082A1 · Gainor et al. · 2016 [cited by applicant]
US 20160220199A1 · Gordon · 2016 [cited by applicant]
US 20170032858A1 · King · 2017 [cited by applicant]
US 20170119324A1 · Wilson et al. · 2017 [cited by applicant]
US 20190063665A1 · LeCote · 2019 [cited by applicant]
US 20190368265A1 · Artwohl et al. · 2019 [cited by applicant]
US 20200100736A1 · Lemer · 2020 [cited by applicant]
US 20200135355A1 · Colling · 2020 [cited by applicant]
US 20220071576A1 · Foster et al. · 2022 [cited by applicant]
US 20220218295A1 · Foster et al. · 2022 [cited by applicant]
US 20220243864A1 · Foster et al. · 2022 [cited by applicant]
US 20230058574A1 · Lemer · 2023 [cited by applicant]
US 20230126167A1 · Wilson et al. · 2023 [cited by applicant]
US 20230181131A1 · Hassid · 2023 [cited by applicant]
US 20240130698A1 · Goldstein et al. · 2024 [cited by applicant]
US 20240173183A1 · Wilson et al. · 2024 [cited by applicant]
US 20240335175A1 · Wilson et al. · 2024 [cited by applicant]
US 20250032069A1 · Foster et al. · 2025 [cited by applicant]
US 20250032070A1 · Wilson et al. · 2025 [cited by applicant]
US 20250195017A1 · Foster et al. · 2025 [cited by applicant]
US 20260069224A1 · Foster et al. · 2026 [cited by applicant]
AU 2020104005A4 · 2021 [cited by applicant]
CN 2349990 · 1999 [cited by applicant]
CN 201175342Y · 2009 [cited by applicant]
CN 202458424U · 2012 [cited by applicant]
CN 204066762U · 2014 [cited by applicant]
CN 205680451U · 2016 [cited by applicant]
CN 206151478U · 2017 [cited by applicant]
CN 108309345A · 2018 [cited by applicant]
CN 112716513A · 2021 [cited by applicant]
CN 113331861A · 2021 [cited by applicant]
CN 214157352U · 2021 [cited by applicant]
CN 214856844U · 2021 [cited by applicant]
CN 114587402A · 2022 [cited by applicant]
CN 115251974A · 2022 [cited by applicant]
CN 116058862A · 2023 [cited by applicant]
CN 110537932B · 2023 [cited by applicant]
CN 118280616A · 2024 [cited by applicant]
CN 118280617A · 2024 [cited by applicant]
DE 102014215448 · 2015 [cited by applicant]
JP 2001120543 · 2001 [cited by applicant]
JP 2009541712A · 2009 [cited by applicant]
JP 2010230311A · 2010 [cited by applicant]
JP 2013512745A · 2013 [cited by applicant]
JP 2018044827A · 2018 [cited by applicant]
JP 2020530574A · 2020 [cited by applicant]
JP 2022529048A · 2022 [cited by applicant]
KR 101081895 · 2011 [cited by applicant]
KR 1020170061691A · 2017 [cited by applicant]
KR 101913840B1 · 2018 [cited by applicant]
KR 1020210027584A · 2021 [cited by applicant]
TW 1666653 · 2018 [cited by applicant]
WO 2016090384A2 · 2016 [cited by applicant]
WO 2017116530A2 · 2017 [cited by applicant]
WO 2018109380A1 · 2018 [cited by applicant]
WO 2019216934A2 · 2019 [cited by applicant]
WO 2020163773A1 · 2020 [cited by applicant]
WO 2020214992A1 · 2020 [cited by applicant]
WO 2024056637A1 · 2024 [cited by applicant]
Caluk, Jasmin, “Radiation Principles and Safety,” Intech, Chapter 3, http://dx/doi.org/10.5772/54033, 2013, 20 pages. [cited by applicant]
Aadco Medical, Inc. “Overhead Barriers” obtained from the world wide web Dec. 29, 2016; http://www.aadcomed.com/products/barriers_shields/overhead_barriers; pp. 1-4 Dec. 29, 2016. [cited by applicant]
ASTM F3094 (ASTM International ““Standard Test Method for Determining Protection Provided by X-ray ShieldingGarments Used in Medical X-ray Fluoroscopy from Sources of Scattered X-Rays”” ASTM vol. 11.03 OccupationalHealt… [cited by applicant]
De La Hera, German ““International Search Report—PCT/US20/17309”” Applicant—Intervention for Life, LLC; p. 20 Apr. 2020. [cited by applicant]
Decision of Dismissal of Amendment received for Japanese Patent Application No. 2020-530444, mailed on Apr. 25, 2023, 15 pages including English translation. [cited by applicant]
Examination Report received for Australian Patent Application No. 2018422761, mailed on May 15, 2023, 04 pages. [cited by applicant]
Extended European Search Report received for European Patent Application No. 23196608.6, mailed on Dec. 11, 2023, 09 pages. [cited by applicant]
Fattal, Peter, et al. “A Novel Complete Radiation Protection System Eliminates Physician Radiation Exposure and Leaded Aprons” Catheterization and Cardiovascular Interventions 81:11-16 (2013) pp. 1-6. [cited by applicant]
First Substantive Examination Report received for Saudi Arabia Application No. 521422707, mailed on Jun. 24, 2023, 18 pages including English translation. [cited by applicant]
IEC 61331-1 (International Electrotechnical Commission, “Protective devices against diagnostic medical X-radiation Part 1: Determination of attenuation properties of materials” (2014). [cited by applicant]
International Preliminary Report on Patentability received for International Application No. PCT/US2020/017309, mailed on Aug. 19, 2021, 10 pages. [cited by applicant]
International Preliminary Report on Patentability received for International Patent Application No. PCT/US2020/028825, mailed on Oct. 28, 2021, 08 pages. [cited by applicant]
International Preliminary Report on Patentability received for International Patent Application No. PCT/US2018/046318, mailed on Feb. 20, 2022, 10 pages. [cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2018/046318, mailed on Nov. 12, 2019, 13 pages. [cited by applicant]
International Search Report and Written Opinion received for International Patent Application No. PCT/US2020/028825, mailed on Aug. 5, 2020, 10 pages. [cited by applicant]
Kenex Co. Lower body x-ray shield 312/E-010; obtained from world wide web Dec. 29, 2016; http://kenex.co.uk/products/x-ray-shielding/x-ray-table-mounted-shields/lower-body-x-ray; pp. 1-3 Dec. 29, 2016. [cited by applicant]
Kenex Co. ““Overhead celing mounted shield 350”” obtained from world wide web Dec. 29, 2016; http://kenex.co.uk/products/x-ray-shielding/overhead-suspended-shields-lamps/overhead; pp. 1-3 Dec. 29, 2016. [cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2021-561838, mailed May 9, 2024, 06 Pages including English Translation. [cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2023-137479, mailed Apr. 30, 2024, 15 Pages including English Translation. [cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2023-137479, mailed Aug. 8, 2024, 06 Pages including English Translation. [cited by applicant]
Notice of Refusal for Japanese Patent Application No. 2021-545836, mailed Mar. 28, 2024, 10 Pages including English Translation. [cited by applicant]
Notice of Refusal for Japanese Patent Application No. 2021-561838, mailed Nov. 17, 2023, 10 Pages including English Translation. [cited by applicant]
Office Action received for Australian Patent Application No. 2018422761, mailed on Feb. 12, 2024, 02 pages. [cited by applicant]
Office Action received for Australian Patent Application No. 2018422761, mailed on Jan. 29, 2024, 03 pages. [cited by applicant]
Office Action received for Canadian Patent Application No. 3072454, mailed on Feb. 7, 2024, 03 pages. [cited by applicant]
Office Action received for Canadian Patent Application No. 3072454, mailed on Jul. 21, 2023, 04 pages. [cited by applicant]
Office Action received for Canadian Patent Application No. 3129066, mailed on Jan. 22, 2024, 04 pages. [cited by applicant]
Office Action received for European Patent Application No. 18908271.2, mailed on May 9, 2022, 05 pages. [cited by applicant]
Office Action received for European Patent Application No. 18908271.2, mailed on Nov. 29, 2023, 05 pages. [cited by applicant]
Office Action received for European Patent Application No. 20710657.6, mailed on Aug. 2, 2024, 05 pages. [cited by applicant]
Office Action received for European Patent Application No. 20710657.6, mailed on Jan. 15, 2024, 6 Pages. [cited by applicant]
Office Action received for European Patent Application No. 20725007.7, mailed on Mar. 1, 2024, 4 Pages. [cited by applicant]
Office Action received for Indian patent Application No. 202147040405, mailed on Apr. 18, 2023, 10 pages. [cited by applicant]
Search Report & Written Opinion received for Singapore patent Application No. 11202108590W, Completed on Apr. 21, 2023, 11 pages. [cited by applicant]
Search Report received for Japanese Patent Application No. 2020-530444, mailed on Jun. 15, 2022, 24 pages including English translation. [cited by applicant]
Second Office Action received for Japanese Patent Application No. 2020-530444, mailed on Nov. 24, 2022, pages including English translation. [cited by applicant]
Strubel, Christine “International Preliminary Report on Patentability and Written Opinion” European Patent Office pp. 1-9 Feb. 11, 2020. [cited by applicant]
Torii, Yuki; “Office Action for Japanese Patent Application No. 2020-530444” Japan Patent Office; Jun. 21, 2022; pp. 1-5. [cited by applicant]
Examiner's Answer for Ex Parte Reexamination for ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Mar. 2, 2026, 19 pages. [cited by applicant]
All you need to know about the C-Arm X-Ray Machines (2018) Blog I Trivitron Healthcare Solutions I Medical Device Company—. https://www.trivitron.com/blog/aii-you-need-to-know-about-the-c-arm-x-ray-machines-2/, 6 pages. [cited by applicant]
Egg Medical, Inc. (2024). EggNest Complete Brochure. https://eggmedicai.com/wp-content/uploads/2024/10/Eggi'-Jest-Complete-Brochure.pdf, 2 pages. [cited by applicant]
Global Cardio Vascular Awards Shortlist Page, available at https://globaicardiovascularawards.corn/globalcardiovascularawards2025/en/page/2025-shortiist, 4 pages. [cited by applicant]
Height—Adjustable, Mobile X-Ray Protective Shield, CSP Medical, Webpage available at: https//csprnedical.corn/height-adjustable-rnobile-x-ray-protective-shield/, accessed Apr. 27, 2024, 3 pages. [cited by applicant]
Kenex Height Adjustable Mobile Shield, Wardray premise, Webpage available at: hitps://wardray-premise corn/products/product/xrsh-310-b/, accessed Apr. 27, 2024, 2 pages. [cited by applicant]
RayShield® Adjust-A-Height Barrier, AA.DCO, Webpage available at: https://www.aadcomed.com/product/rayshield-adjust-a-height-barrier/, accessed Apr. 27, 2024, 2 pages. [cited by applicant]
Anon “Testimonial from Dr. T Eagan, Interventional Cardiologist” Jan. 6, 2021. Available at https://www.youtube.com/watch?v === DU3zi-biw4o, 1 page. [cited by applicant]
Anon 2024. Rampart IC Products. Web page Available at https://www.rampartic.com/products, 7pages. [cited by applicant]
Anon J. “Rampart IC M1128 Protect Yourself, Your Team, and Your Career” last visited Mar. 17, 2025. Available at https://static1.squarespace.com/static/5c7d5feda9ab952d5c179b80/t!652712121482124ba52840f6/1697059346668/M… [cited by applicant]
Anon. “Rampart IC Tradeshow Video Loop—Feb. 2023.” Mar. 13, 2023. Available at https://www.youtube.com/ watch?v=JdjKpPtPv81, 2 pages. [cited by applicant]
Anon. “Testimonial from Dr. Mustafa Ahmed, Interventional Cardiologist” Jan. 6, 2021. Available at https://www.youtube.com/watch?v=WowshCz-3ZM, 1 page. [cited by applicant]
Anon. Rampart M1128 Defender Brochure (2023), 1 page. [cited by applicant]
Barraclough et al. (2024). Modern radiation safety in the Cardiology Catheter Laboratory, Are we doing enough? Heart Lung and Circulation, 33, 2 pages. [cited by applicant]
Biswas et al. (2022) TCT-248 Systematic comparison of the efficacy of various radiation protection devices in reducing operator scatter radiation dose in the cardiac Chatherisation Laboratory. Journal of the American Co… [cited by applicant]
Crowhurst et al., (2023). Trial of a novel radiation shielding device to protect staff in the cardiac catheter laboratory. The American Journal of Cardiology, 203, 7 pages. [cited by applicant]
Document 1, filed with Document filed May 31, 2024, “Complaint For Patent Infringement”, in Case 1:24-cv-00643-JCG (In The United States District Court For The District Of Delaware), 5 pages. [cited by applicant]
Document 12, filed with Document filed Jul. 22, 2024, “Egg Medical, Inc.'s Answer and Counterclaims to Plaintiff's Complaint”, in Case 1:24-cv-00643-JCG (In The United States District Court For The District of Delaware)… [cited by applicant]
Document 23, filed with Document filed Aug. 21, 2024, “Plaintiff's Answer to Defendant's Counterclaims”, in Case 1:24-cv-00643-JCG (In The United States District Court For The District of Delaware), 5 pages. [cited by applicant]
Egg Medical, Inc. (2024). EggNest XR User and Service Manual. https://eggmedical.corn/wp-content/uploads/2024/10/2298rE-User-Manual-XR.pdf; as of Jul. 25, 2024, the Radiation Medical device was not approved for general … [cited by applicant]
Exhibit B, Document 1-1, filed with Document filed May 31, 2024, “Complaint For Patent Infringement”, in Case 1:24-cv-00643-JCG (In The United States District Court For The District of Delaware), 6 pages. [cited by applicant]
Examination Report received for New Zealand Patent Application No. 778798, mailed on Mar. 18, 2025, 05 pages. [cited by applicant]
First notice of examination for Chinese Patent Application No. 202080026475.1, mailed Jan. 20, 2025, 16 Pages including English Translation. [cited by applicant]
Global Cardio Vascular Awards Home Page, available at https://globalcardiovascularawards.com/globalcardiovascularawards2025/en/page/horne, 3 pages. [cited by applicant]
Notice of Reasons for Refusal received for Japanese Patent Application No. 2024-231552, mailed on Feb. 13, 2025, 09 pages including English translation. [cited by applicant]
Office Action received for Australian Patent Application No. 2020219362, mailed on Jan. 15, 2025, 03 pages. [cited by applicant]
Office Action received for Australian Patent Application No. 2024200350, mailed on Feb. 18, 2025, 04 pages. [cited by applicant]
Office Action received for Canadian Patent Application No. 3072454, mailed on Oct. 25, 2024, 03 pages. [cited by applicant]
Office Action received for European Patent Application No. 20725007.7, mailed on Mar. 4, 2025, 05 pages. [cited by applicant]
Orme et al. (2015). Occupational Health Hazards of Working in the Interventional Laboratory Journal of the American College of Cardiology, 65(8), 7 pages. [cited by applicant]
Patel et al. (2024). Implementing a ‘Lead [Apron]-Free’ cardiac catheterization: current status. Current Cardiology Reports, 26(9), 102.9 pages. [cited by applicant]
Rampart Financial Solutions Brochure, 2 pages. [cited by applicant]
RAMPART ic. (Jan. 6, 2021). Testimonial from Dr. Mustafa Ahmed, Interventional Cardiologist YouTube. https://www.youtube.com/watch?v ==WowshCz:--3ZM, 1 page. [cited by applicant]
RAMPART ic. (Jan. 6, 2021). Testimonial from Dr. T. Eagan, Interventional Cardiologist. YouTube. https://www.youtube.com/watch?v=DL6zi-biw4o, 1 page. [cited by applicant]
Request for the submission of an opinion for Korean Patent Application No. 10-2021-7028181, mailed Oct. 4, 2024, 17 Pages including English Translation. [cited by applicant]
Roguin et al. (2013). Brain and neck tumors among physicians performing interventional procedures The American Journal of Cardiology, 111(9), 5 pages. [cited by applicant]
Search Report received for Chinese Patent Application No. 202080044365.8, mailed on Apr. 30, 2025, 02 pages. [cited by applicant]
Smith, L. (2024). “A novel shielding device for cardiac cath labs,” Health Physics, 8 pages. [cited by applicant]
United States Environmental Protection Agency. (n.d.). Significant Discoveries and the History of Radiation Protection. https://www.epa.gov/sites/default/files/2018-12/docurnents/significant_discoveries_history_radiatio… [cited by applicant]
Lisko et al. (2023). Radiation Exposure Using Rampart vs Standard Lead Aprons and Shields, Journal of the Society for Cardiovascular Angiography & Interventions, 3:10, 6 pages. [cited by applicant]
Vlastra, W, et al. (2017) Efficacy of the RADPAD Protection Drape in Reducing Operators' Radiation Exposure in the Catheterization Laboratory. Circulation: Cardiovascular Interventions, 7 pages. [cited by applicant]
Internet Archive WaybackMachine, Merriam Webster Dictionary, Definition of Mast, https://vW1W.merriam-webster.com/ dictionary/mast, Jun. 8, 2017, 1 page. [cited by applicant]
Internet Archive WaybackMachine, Merriam Webster Dictionary, Definition of Boom, https://vvvvw.merriam-webster.com/dictionary/boom, May 11, 2017, 1 page. [cited by applicant]
Office Action received for European Patent Application No. 20710657.6, mailed on Dec. 23, 2024, 6 pages. [cited by applicant]
Office Action received for Canadian Patent Application No. 3129066, mailed on Nov. 25, 2024, 4 pages. [cited by applicant]
Order Granting Request for Ex Parte Reexamination for Ex Parte ReExam U.S. Appl. No. 90/019,649 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Oct. 7, 2024, 16 pages. [cited by applicant]
Order Granting Request for Ex Parte Reexamination for Ex Parte ReExam U.S. Appl. No. 90/019,650 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Oct. 7, 2024, 15 pages. [cited by applicant]
Order Granting Request for Ex Parte Reexamination for Ex Parte ReExam U.S. Appl. No. 90/019,651, Applicant: Rampart IC, Inc., mailed Oct. 7, 2024, 14 pages. [cited by applicant]
Decision Sua Sponte Merging Proceedings for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Oct. 17, 2024, 6 pages. [cited by applicant]
Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Dec. 17, 2024, 13 pages. [cited by applicant]
Response to Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., submitted on Mar. 17, 2025, 141 pages. [cited by applicant]
Exhibit A: Response Non-Final Office Action for Ex Part ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Curriculum Vitea of Justin Vahn Lewis, CPA, CVA, CFF (Jan. 2025), submitted … [cited by applicant]
Exhibit B: Response Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Schedules, submitted Mar. 17, 2025, 5 pages. [cited by applicant]
Exhibit C: Response Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Declaration of Justin V. Lewis, submitted Mar. 17, 2025, 44 pages. [cited by applicant]
Exhibit W: Response Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Declaration of Matthew R. Stelljes, submitted Mar. 17, 2025, 5 pages. [cited by applicant]
Exhibit AA: Response Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056,WestLaw: United States of Appeals, Federal Circuit: [cited by applicant]
Exhibit AB: Response Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, WestLaw: United States of Appeals, Federal Circuit: [cited by applicant]
Exhibit AC: Response Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, WestLaw: United States of Appeals, Federal Circuit: [cited by applicant]
Supplemental Amendment to Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651, Applicant: Rampart IC, Inc., mailed Mar. 24, 2025, 8 pages. [cited by applicant]
Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Apr. 7, 2025, 15 pages. [cited by applicant]
Response to Non-Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., filed on Jun. 9, 2025,45 pages. [cited by applicant]
Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Jul. 14, 2025, 19 pages. [cited by applicant]
Response to Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., submitted Oct. 14, 2025, 125 pages. [cited by applicant]
Exhibit AG: Response to Final Office Action for ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Declaration of Dr. Rhain Davies, Applicant: Rampart IC, Inc., submitted Oct. 14, 202… [cited by applicant]
Table of Authorities and Administrative Reports and Decisions (Exhibit AH-BP) accompanying Response to Final Office Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,0… [cited by applicant]
Advisory Action for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., mailed Oct. 27, 2025, 23 pages. [cited by applicant]
Notice of Appeal for Ex Parte ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., submitted Nov. 14, 2025, 2 pages. [cited by applicant]
Appeal Brief for ReExam U.S. Appl. Nos. 90/019,651, 90/019,651, 90/019,651 of U.S. Pat. No. 11,660,056, Applicant: Rampart IC, Inc., submitted Jan. 14, 2026, 48 pages. [cited by applicant]